PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer
PTPN9在曲妥珠单抗治疗期间调节HER3磷酸化，PTPN9的缺失是HER2阳性乳腺癌曲妥珠单抗耐药的潜在生物标志物。
期刊:Cancer Communications
影响因子:24.9
doi:10.1002/cac2.12632
Azad, Abul; Arshad, Maryam; Generali, Daniele; Feldinger, Katharina; Gijsen, Merel; Strina, Carla; Cappelletti, Mariarosa; Andreis, Daniele; Leek, Russell; Haider, Syed; Kellokumpu-Lehtinen, Pirkko-Liisa; Roxanis, Ioannis; Harris, Adrian Llewellyn; Shaaban, Abeer Mahmoud; Joensuu, Heikki; Kong, Anthony
